Synthesis Sequencing Segment to Lead Market between 2021 and 2028

According to our new research study on "US DNA Digital Data Storage Market Forecast to 2028 – COVID-19 Impact and Analysis – by Sequencing, Application, and End User," the market is expected to reach US$ 711.92 million by 2028 from US$ 21.40 million in 2021; it is estimated to grow at a CAGR of 65.0% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The active investments and business innovation in DNA data storage and presence of DNA digital data storage-related service providers propel the demand for DNA digital data storage. However, the availability of alternate options and associated limitations hamper the market growth.

Based on sequencing, the US DNA digital data storage market is segmented into synthesis sequencing, ion semiconductor sequencing, chain termination sequencing, ligation sequencing, and nanopore sequencing. The synthesis sequencing segment held the largest share of the market in 2021. However, the nanopore sequencing segment is anticipated to register the highest CAGR in the market during the forecast period. Sequencing by synthesis (SBS) technology uses four fluorescently labeled nucleotides to sequence the tens of millions of clusters on the flow cell surface in parallel. The market players are developing and offering solutions related to SBS. For instance, in January 2018, Illumina Inc. launched iSeq 100, a next-generation sequencing (NGS) system that delivers excellent data accuracy at a low capital cost. The technology is virtually available to any lab. The system is a blend of the company’s proven SBS chemistry and complementary metal-oxide-semiconductor (CMOS) detection technology.

Impact of COVID-19 Pandemic on US DNA Digital Data Storage Market

The COVID-19 pandemic has adversely affected industries, such as manufacturing and healthcare, globally and influenced the DNA digital data storage market growth. The ongoing pandemic has also raised the demand for advanced healthcare facilities, and increased the burden on the healthcare industry concerning isolation, prevention, and providing treatment to COVID-19 infected patients. As a result, governments took extreme measures that affected economies and industries in various countries due to lockdowns, business shutdowns, and limited workforce. The company’s revenue also dropped due to the impact of the COVID-19 pandemic-related disruptions in operations. However, DNA data storage technology is still developing, and its use by the organizations is limited, as the storage method is costly, so the components required and the supplies are as per demand of the customers. Thus, the ongoing pandemic has a minimal impact on the DNA digital data storage market. The market is expected to propel after the upliftment of restrictive measure in the coming years.

Twist Bioscience; Illumina, Inc.; Agilent Technologies, Inc.; Molecular Assemblies; Quantum Corporation; CATALOG; Microsoft Corporation; Iridia, Inc.; F. HOFFMANN-LA ROCHE LTD.; and DNA Script are among the leading companies operating in the US DNA digital data storage market. 

The report segments the US DNA Digital Data Storage market as follows:

The US DNA digital data storage market is segmented on the basis of sequencing, application, and end user. Based on sequencing, the market is segmented into synthesis sequencing, ion semiconductor sequencing, chain termination sequencing, ligation sequencing, and nanopore sequencing. Based on application, the US DNA digital data storage market is segmented into diagnostic research, personalized medicine, and others. Based on end user, the market is segmented into academics and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com